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Objective
To investigate the efficacy of polymyxin-B direct hemo-
perfusion (PMX-DHP) in terms of improving clinical
conditions and life prognosis in severe sepsis cases.
SUBJECTS AND METHODS
The subjects were 88 cases admitted to our hospital ICU
between April 2010 and July 2014 with the diagnosis of
severe septic shock requiring continuous norepinephrine
injection (Cathecholamine Index≧10). We investigated
PMX-DHP efficacy by retrospectively comparing 63 cases
that underwent PMX-DHP with 25 cases that did not.
Results
The two groups did not differ significantly in age,
APACHE II score, SOFA score, infection focus, and bac-
terial species. The 28-day mortality was 32% in the PMX-
DHP group and 40% in the non-PMX-DHP group, but
this difference was not significant. The ⊿CAI (the change
in Cathecholamine Index 24 hours after PMX-DHP
administration) and the infusion volume 24 hours after
PMX-DHP administration were significantly different
between the two groups. Multivariate analysis identified
⊿CAI and SOFA score as independent prognostic factors.
Sub-analysis showed no significant difference in 28-day
mortality in sepsis cases involving the lower-gastrointest-
inal tracts, but a trend for improvement in 28-day mortal-
ity was observed in sepsis cases where the infection focus
could not be removed, such as pneumonia, and in severe
sepsis cases whose APACHE II score exceeded 25.
Conclusions
PMX-DHP may improve life prognosis of septic shock
cases under certain conditions. We have to clarify the
indication criteria for PMX-DHP and accumulate data
by additional investigations of severe septic cases to pur-
sue the possibilities for further improvements in life
prognosis.
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